*|MC:SUBJECT|*
bioRN News April 2026
Dear *|FNAME|* *|LNAME|*,

April at bioRN strengthens Europe´s most powerful life science corridor

April sent a signal that will reach far beyond the month: the mayors of Heidelberg and Mainz, Eckart Würzner and Nino Haase, signed a Memorandum of Understanding to strengthen collaboration between both life science regions.

For bioRN, this is far more than a symbolic gesture. Thought of as one connected innovation space, the Rhine-Main and Rhine-Neckar regions form one of Europe’s most dynamic life science corridors. This MoU is the accelerator for the next stage of development—through shared platforms, stronger networks and faster translation of research into application. Read the press news

The same spirit was also evident at the German Biotech Days 2026 in Leipzig. BioRN was represented by Dr. Julia Schaft as spokesperson for the AK BioRegio and Friedemann Loos as a jury member for the Innovation Award of the German BioRegions. One message stood out clearly: Germany is serious about biotechnology. Anchored as one of the six pillars of the national high-tech strategy and backed by strong political commitment, there is great ambition. The real question now is speed: How quickly can innovation achieve real impact?

At our bioRN Lounge, Katharina Hölzle brought exactly this perspective to the stage. Her impulse on “Foresight for Future Readiness” made one thing clear: foresight is not a luxury - it is a muscle we must train. Baden-Württemberg is already one of the world’s leading innovation regions, but stronger lighthouse projects, real regulatory sandboxes and greater technological sovereignty are essential to stay ahead. Read more

At the bioRN MarCom Breakfast, more than 40 MarCom professionals explored how AI is changing communication. One shared conclusion: AI can support us-but empathy, authenticity and strong storytelling remain deeply human strengths. And these strengths are best expressed in face-to-face meetings.
That´s why we are already looking forward to seeing you again! 

Meet bioRN in May 2026

1) 4.-5. May: Swiss Biotech Days. Meet bioRN at the Global Village , Booth GV7.1 Level 3   
3) 8 May, 9-10:30am (online via Zoom): bioRN HR Breakfast Community: Neue Wege im Recruiting: StudiumPLUS, Register here 
2) 18.-20 May: At re:publica 2026 in Berlin, bioRN will showcase its sucess stories together with 20 cluster and campus initiatives of the Federal Ministry of Research, Technology, and Space (BMFTR). more Information here
3) 19 May, 6pm @Urban Kitchen Heidelberg: bioRN Lounge with Dr. Alba Diz-Muñoz, Interim Head of the Cell Biology and Biophysics Unit and Research Group Leader ERC and ADI Investigator at EMBL on .>> More than the sum: Cellular bioengineering to study cell mechanics and function. Register here
4) 11 June at 12 pm @Business Development Center Heidelberg: Presentation of the German Biotechnology Report,  More information here

Don´t miss further news from the network at the bioRN website.
Find out about new bioRN events here and get the latest news about funding and growth opportunities at
03 | Opportunities.

We wish you a happy and sunny 1 May. 

Kind regards,

Stephanie Füller 
PR Manager
bioRN Life Science Cluster 
LinkedIn
Twitter
Website
01 | Research Highlights & News
02 | New Members
03 | Event Spotlights
04 | Event Calendar & Discounts
05 | Opportunities
06 | Open Positions
01 | Research Highlights & News

Bayer AG: AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease [more

BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering [more

New paper by BioThrust : 𝗡𝗞-𝟵𝟮 𝗰𝗲𝗹𝗹 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗯𝗲𝗻𝗰𝗵𝗺𝗮𝗿𝗸 𝗮𝘁 𝟮𝗟 𝘀𝗰𝗮𝗹𝗲! [more

DKFZ:
  • Higher Biological Age – Higher Cancer Risk [more]
  • Paul Martini Prize for Professor Alwin Krämer [more]
Tony Hyman starts as EMBL Director General [more]

EMBL-EM: TMapping the microbial communities beneath our feet and inside our guts [more]

Experimentica: A mouse model for Dry Eye Disease [more]

Fraunhofer IGB: Tailor-Made Fertilization [more]

Fraunhofer IPA wins the “euRobotics Technology Transfer Award” together with Trumpf and Lorch [more]

Genetic Engineering Heidelberg GmbH (Gen-H): New Mouse Model: Rhabdomyosarcoma GEMM [more]

Gilead to Acquire Tubulis Adding Potentially Best-In-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline [more]

Heidelberg Institute for Theoretical Studies (HITS): The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase [more]

NMI Natural and Medical Sciences Institute: 3D-Printed Tissue Substitute [more]

Sanofi: 
  • Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria [more]
  • Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease [more]
New Publication from Sciomics GmbH: Fimepinostat Promotes Apoptosis and Decreases Cytokine Secretion in NF2-Related Human Schwannoma Cells [more]

SPT Labtech and EMBL GeneCore Collaborate to Advance Fully Walkaway Automation in Genomics Workflows [more]

UKHD:
  • Molecular signature linked to aggressive growth of head and neck tumors discovered [more]
  • Digital recording of health status [more]
  • Interdisciplinary Care for Elderly Trauma Patients: Heidelberg University Hospital’s Center for Geriatric Trauma Receives Certification [more]
  • Two German Cancer Awards for Researchers at Heidelberg University’s Faculty of Medicine [more]

02 | New Members


More information about the new members and other bioRN members can be found here.
treatlink GmbH is developing AI-driven solutions to improve glioblastoma (GBM) treatment and drug development. By building a highly standardized proprietary biobank and comprehensive multi-omics dataset, the company aims to create advanced AI models that better understand GBM biology, improve patient stratification in clinical trials, and support the development of more effective therapies for currently incurable cancers.

03 | Opportunities


In this section we provide selected information on funding calls and events. On our website in the section startup support you will find a calendar with more Open Calls, Pitches, Knowledge Transfer and Closings.

Open Calls:  

  • EIC Pathfinder Open Call 2026: High-risk, interdisciplinary research projects aimed at developing future technologies Deadline:12 May [more]
Pitches & Prices
  • Life Science Investors´Day Heidelberg, 24 September: Stage for short pitches and direct conversations with investors - Apply now! [more]
     
Internationalisation:
  • Business Delegation for German companies in the medical biotechnology sector 19.-23 Oktober, Japan, Registration Deadline:22 May [more]
  • Last Call: Biopharmaceutical Business Delegation -23.-31. May 2026 China: Deadline 30 April [more] 

    For  more information, contact Daniela Weber (dw@biorn.org)
Other:
  • EU Feedback Period: Deadline 19 May  more - This proposed recommendation will help Member States organise evidence-based screening for cardiovascular diseases tailored to their specific health systems and national and regional situations.
Closings: 
  • Kurma Partners, an Eurazeo Group Compagny, closes €215 Million Biofund IV more

04 | Event Spotlights

05 | Event Calendar & Discounts

Open Innovation Day – Circular Health: Innovation für nachhaltige Versorgung
May 04, 2026 - Stuttgart, Germany >>
 
Swiss Biotech Day 2026
May 04-05, 2026 - Basel, Switzerland >>
Ticket Discount & Global Village Participation

 
Global Innovation Summit 2026
May 06, 2026 - Basel, Switzerland >>
 
Symposium: Accelerating Translation from Discovery to Application
May 06, 2026 - NMI Reutlingen, Germany >>
 
Look Inside! Microscopy Meeting Mainz 2026
May 06, 2026 - Mainz, Germany >>
 
X-Linker Corporate Health & Safety
May 06, 2026 - Mannheim, Germany >>
15 Free Tickets available!

 
4th SIMPLAIX Workshop on Machine Learning for Multiscale Molecular Modeling
May 06-08, 2026 - Heidelberg, Germany >>
 
bioRN Lounge with Dr. Alba Diz-Muñoz (EMBL): More than the sum: Cellular bioengineering to study cell mechanics and function
May 19, 2026 - Heidelberg, Germany >>
 
CONTACT 2026 – 25th Life Science Job Fair
May 20, 2026 - Heidelberg, Germany >>
 
Meet & Match Virus-based Technologies
May 20, 2026 - Biberach an der Riß, Germany >>
 
CDMO Live Europe 2026
May 19-21, 2026 - Rotterdam, Netherlands >>
20 % discount for members.
SaxoCell Conference 2026
June 02-03, 2026 - Dresden, Germany >>
20 % discount for members.

 
bio:cap europe 2026
June 02-03, 2026 - Berlin, Germany >>
60 % Discount on Tickets

 
Knowledge for Growth 2026
June 03-04, 2026 - Antwerp, Belgium >>
 
HLTH Europe 2026
June 15-18, 2026 - Amsterdam, Netherlands >> 
Ticket Discount for Members!


 
qPCR-Workshop: Richtige Anwendung für mehr Routine im Laboralltag
June 23-24, 2026 - Walldorf, Germany >>
15 % Discount for Members!

 
BayOConnect 2026
June 30 - July 01, 2026 - Munich, Germany >>
15 % Discount for Members!

 
Nordic Life Science Days 2026
September 08-09, 2036 - Stockholm, Sweden >>
Participate @ German Pavilion
Registration deadline: June 03, 2026

 
BIOSPAIN 2026
September 29-Oct.1, 2036 - Bilbao, Spain >>
10 % Discount for Members

 
Festival of Biologics 2026
October 13-15, 2026 - Basel, Switzerland >>
20 % Discount for Members!

 
Bio-Europe 2026
November 09-11, 2026 - Köln, Germany >>
12% Discount for Members!

 
BioFIT and MedFIT 2026
December 10-11, 2026 - Marseille, France >>
20 % Discount for Members!

 
Curious 2027 comes to HEIDELBERG
July 6-7 2027  >>
SAVE THE DATE!

 

06 | Open Positions
 

Ascendis Pharma

  • System Manager - Laboratory Enterprise Systems [more]

PROGEN:

  • Auftragssachbearbeiter (m/w/d) - Vollzeit, Heidelberg, Deutschland [more]
  • Junior Product Manager (m/w/d) - Full time, Heidelberg, Deutschland [more]

QuantiLight:

  • Founders’ Associate – Working Student [more]
  • Head of Commercial Strategy [more]

VectorBuilder: 
  • Territory Manager, DACH Region (Frankfurt) [more]
Tweet Tweet
Forward Forward
Share Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Stephanie Füller

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*